TTR and amyloidosis: As demonstrated in the French FAP Network, which consists of a coordinating center in Paris and specialized rare neuromuscular disease centers located across the country [36], a referral network (Fig. 2) is crucial for the appropriate management of TTR gene mutation carriers and patients with ATTRv amyloidosis [61, 62].